Ursodeoxycholic acid activates AMPK and influences the interaction of Bcl-2/Beclin-1 and Bcl-2/Bax complexes in NAFLD rats, thereby inhibiting apoptosis [121]. Here, BCL2 is linked to metabolic dysfunction-associated steatotic liver disease.